All
Evorpacept With Keytruda Did Not Elicit Responses in Head and Neck Cancer
In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 and ASPEN trials.
ctDNA Clearance Linked to Improved Survival in Oncogene-Driven NSCLC
Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.
The Fearless Patient Advocate
Kathleen Coughlin, although small in stature, is often referred to as the “Bulldozer.”
Working to Address Unmet Medical Needs in MPNs
CURE spoke with John Crispino, the director of the division of experimental hematology at St. Jude Children’s Research Hospital.
First Patient Enrolled in ARID II Trial for Prostate Cancer Treatment
The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after prostate cancer surgery.
Taking Charge of My Care and Advocacy Following a Cancer Diagnosis
After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.
FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.
Dose-Limiting Toxicity Observation Phase Completed in CRS Trial for Lymphoma
In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation period was successfully completed.
Early Symptoms, Risk Factors and Treatment Options for Esophageal Cancer
In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing research to improve patient outcomes.
Optune Lua Receives CE Mark in Europe for Metastatic NSCLC
Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.
How to Best Navigate a Diagnosis of Lung and Head and Neck Cancer
Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.
Joy Anderson Reflects on Her Diagnosis of a Rare Blood Cancer
A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.
The Burst of Spring: Reflection for Those Living with Cancer
As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop my treatment. Life is a gift.
Ivonescimab Plus Chemo May Slow Advanced NSCLC Progression
In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free survival results.
FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
First Patient Dosed with AP402 in a Trial for HER2 Advanced Tumors
Advocacy and ‘Radiating Valor’ Have a Transformative Impact
Air Matters: Radon and the Environment
Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T
LCI Launches Screening Saves Program
Overcoming Barriers to Emotional and Physical Support in Cancer Care
An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.
Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025
People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate.
Remission is Not a Cure for Follicular Lymphoma, or Any Cancer
It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.
First Patient with CD5-Positive T-Cell Lymphoma Dosed with MB-105
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
Oncodetect Test Aims to Detect Recurrence Risk Across Solid Tumors
The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence risk and treatment decisions.
Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment
Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder cancer, based on the NIAGARA trial.
Aspiring to Make a Difference for Immigrants
“Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.”
Raising Awareness for Adolescents and Young Adults with Cancer
Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.
Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.
My 11-Year Metastatic Breast Cancer Story Defied the Standard Path
Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.
